Page last updated: 2024-08-17

quinoxalines and Infection

quinoxalines has been researched along with Infection in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bourliere, M	1
COULTHARD, CE; HALE, LJ	1

Other Studies

2 other study(ies) available for quinoxalines and Infection

Article	Year
Retreatment Options for Patients Who Failed Direct-Acting Antiviral Regimens Containing NS5A Inhibitors: Is Glecaprevir/Pibrentasvir a Valid and Robust Option? Gastroenterology, 2019, Volume: 157, Issue:6 Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Combinations; Genotype; Hepacivirus; Humans; Infections; Lactams, Macrocyclic; Leucine; Proline; Pyrrolidines; Quinoxalines; Retreatment; Sofosbuvir; Sulfonamides; Treatment Failure	2019
The treatment of experimental bacillary infections of mice with quinoxaline 1:4 di-N-oxide. British journal of pharmacology and chemotherapy, 1955, Volume: 10, Issue:3 Topics: Animals; Infections; Mice; Oxides; Quinolines; Quinoxalines	1955

Article

Year

Retreatment Options for Patients Who Failed Direct-Acting Antiviral Regimens Containing NS5A Inhibitors: Is Glecaprevir/Pibrentasvir a Valid and Robust Option?

Gastroenterology, 2019, Volume: 157, Issue:6

Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Combinations; Genotype; Hepacivirus; Humans; Infections; Lactams, Macrocyclic; Leucine; Proline; Pyrrolidines; Quinoxalines; Retreatment; Sofosbuvir; Sulfonamides; Treatment Failure

2019

The treatment of experimental bacillary infections of mice with quinoxaline 1:4 di-N-oxide.

British journal of pharmacology and chemotherapy, 1955, Volume: 10, Issue:3

Topics: Animals; Infections; Mice; Oxides; Quinolines; Quinoxalines

1955